Growth Metrics

TransMedics (TMDX) Receivables - Net (2018 - 2026)

TransMedics has reported Receivables - Net over the past 8 years, most recently at $84.3 million for Q4 2025.

  • For Q4 2025, Receivables - Net fell 13.75% year-over-year to $84.3 million; the TTM value through Dec 2025 reached $84.3 million, down 13.75%, while the annual FY2025 figure was $84.3 million, 13.75% down from the prior year.
  • Receivables - Net for Q4 2025 was $84.3 million at TransMedics, up from $80.7 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $142.0 million in Q1 2025 and troughed at $4.1 million in Q3 2021.
  • A 5-year average of $53.6 million and a median of $54.1 million in 2023 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: plummeted 32.42% in 2021 and later soared 430.96% in 2022.
  • Year by year, Receivables - Net stood at $5.9 million in 2021, then soared by 365.3% to $27.6 million in 2022, then soared by 130.26% to $63.6 million in 2023, then surged by 53.71% to $97.7 million in 2024, then fell by 13.75% to $84.3 million in 2025.
  • Business Quant data shows Receivables - Net for TMDX at $84.3 million in Q4 2025, $80.7 million in Q3 2025, and $104.9 million in Q2 2025.